Daiwa Securities Group Inc. 4 D Molecular Therapeutics, Inc. Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 184 shares of FDMT stock, worth $1,637. This represents 0.0% of its overall portfolio holdings.
Number of Shares
184
Previous 9,578
98.08%
Holding current value
$1,637
Previous $31,000
96.77%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding FDMT
# of Institutions
123Shares Held
41.2MCall Options Held
19KPut Options Held
38.3K-
Black Rock Inc. New York, NY4.9MShares$43.6 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA4.63MShares$41.2 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$40.6 Million0.37% of portfolio
-
Goldman Sachs Group Inc New York, NY4.16MShares$37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$24.4 Million0.0% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $288M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...